Fosun expects 1H profit attributable to owners at RMB 1.5 billion-RMB 1.8 billionPUBT·17 hours ago02196-0.61%00656+7.43%
Virax Biolabs signs Fosun Diagnostics supply deal for ImmuneSelect in six Southeast Asian marketsPUBT·Jul 16 at 06:33 AMVRAX+1.38%02196-0.61%
Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement | VRAX Stock NewsStockTitan·Jul 15 at 10:30 PMVRAX+1.38%600196+0.22%
Fosun Pharma Shenzhen wins China approval to start Phase I trial of FXR0906 for hypertriglyceridemiaPUBT·Jul 15 at 05:14 AM02196-0.61%600196+0.22%
Shanghai Fosun Pharmaceutical (Group) Co (SFOSF) Gets a Hold from HSBCTip Ranks·Jul 13 at 07:27 PM600196+0.22%02196-0.61%
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watchrttnews·Jul 9 at 09:55 PMFBRX-0.16%CNTB-1.44%
Virax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun Diagnostics | VRAX Stock NewsStockTitan·Jul 8 at 10:30 PMVRAX+1.38%02196-0.61%
JUNSHI BIO Opens 11.11% Higher After Signing Licensing Agreement with Fosun WanbangAASTOCKS News·Jul 1 at 08:50 PM01877-2.69%688180-2.72%
